Predictors of Hypoglycemia in the ASPIRE In-Home Study and Effects of Automatic Suspension of Insulin Delivery

Background: Hypoglycemia varies between patients with type 1 diabetes and is the main obstacle to therapy intensification. We investigated known and potential risk factors for hypoglycemia in subjects with type 1 diabetes. Method: In the ASPIRE In-Home study (NCT01497938), a randomized trial of the threshold suspend (TS) feature of sensor-augmented insulin pump (SAP) therapy, subjects’ propensity to nocturnal hypoglycemia (NH) was established in a 2-week run-in phase and assessed in a 3-month study phase via continuous glucose monitoring. Categorical variables were tested for association with NH rates in both phases. Results: Elevated rates of NH were significantly associated with baseline A1C ≤7%, with bolus insulin deliveries unassisted by the bolus estimation calculator, and with assignment to the control group during the study phase. Conclusions: Routine use of the TS feature and the bolus estimation calculator are strategies that may reduce the risk of NH.

[1]  George Dailey,et al.  Effectiveness of sensor-augmented insulin-pump therapy in type 1 diabetes. , 2010, The New England journal of medicine.

[2]  D. Klonoff,et al.  The ASPIRE Study: Design and Methods of an In-Clinic Crossover Trial on the Efficacy of Automatic Insulin Pump Suspension in Exercise-Induced Hypoglycemia , 2011, Journal of diabetes science and technology.

[3]  F. Chiarelli,et al.  Variables associated with severe hypoglycemia in children and adolescents with type 1 diabetes: a population‐based study , 2011, Pediatric diabetes.

[4]  Martin Holder,et al.  Prevention of hypoglycemia by using low glucose suspend function in sensor-augmented pump therapy. , 2011, Diabetes technology & therapeutics.

[5]  Sina Askari,et al.  Usage and Effectiveness of the Low Glucose Suspend Feature of the Medtronic Paradigm Veo Insulin Pump , 2011, Journal of diabetes science and technology.

[6]  David C Klonoff,et al.  Reduction in duration of hypoglycemia by automatic suspension of insulin delivery: the in-clinic ASPIRE study. , 2012, Diabetes technology & therapeutics.

[7]  T. Jones,et al.  Effect of sensor-augmented insulin pump therapy and automated insulin suspension vs standard insulin pump therapy on hypoglycemia in patients with type 1 diabetes: a randomized clinical trial. , 2013, JAMA.

[8]  D. Golicki,et al.  The effect of using the insulin pump bolus calculator compared to standard insulin dosage calculations in patients with type 1 diabetes mellitus - systematic review. , 2013, Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association.

[9]  D. Klonoff,et al.  ASPIRE in-Home: Rationale, Design, and Methods of a Study to Evaluate the Safety and Efficacy of Automatic Insulin Suspension for Nocturnal Hypoglycemia , 2013, Journal of diabetes science and technology.

[10]  D. Klonoff,et al.  Threshold-based insulin-pump interruption for reduction of hypoglycemia. , 2013, The New England journal of medicine.

[11]  S. Dagogo-Jack,et al.  Hypoglycemia in Patients with Type 1 Diabetes: Epidemiology, Pathogenesis, and Prevention , 2013, Current Diabetes Reports.

[12]  R. Beck,et al.  Severe hypoglycemia and diabetic ketoacidosis among youth with type 1 diabetes in the T1D Exchange clinic registry , 2013, Pediatric diabetes.

[13]  S. Fredheim,et al.  Prevalence and predictors of severe hypoglycemia in Danish children and adolescents with diabetes , 2015, Pediatric diabetes.

[14]  J. Welsh,et al.  Patient behaviors associated with optimum glycemic outcomes with sensor-augmented pump therapy: insights from the STAR 3 study. , 2015, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.

[15]  Rajiv V Shah,et al.  Retrospective analysis of the real-world use of the threshold suspend feature of sensor-augmented insulin pumps. , 2015, Diabetes technology & therapeutics.

[16]  Darrell M. Wilson,et al.  Factors associated with nocturnal hypoglycemia in at-risk adolescents and young adults with type 1 diabetes. , 2015, Diabetes technology & therapeutics.